Glycogen phosphorylase-a is a common target for anti-diabetic effect of iridoid and secoiridoid glycosides

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 16, Issue 4, 2013, Pages 530-540

  Vaidya, Hitesh B ^a   Ahmed, Abeer A ^a   Goyal, Ramesh K ^b   Cheema, Sukhinder K ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b AHMEDABAD UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

8 O ACETYLHARPAGIDE; ANHYDROGENIPIN; ATORVASTATIN; AUCUBIN; GARDENIA JASMINOIDES EXTRACT; GENIPIN; GLYCOGEN PHOSPHORYLASE; HACHIMIJIOGAN; HARPAGOSIDE B; IRIDOID; KOELZIOSIDE; LOGANIC ACID; LOGANIN; MORRONISIDE; OLEUROPEIN; SCROPOLIOSIDE D2; SECOIRIDOID; SWERTIAMARIN; TOCOPHEROL DERIVATIVE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2;

ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; DIABETES MELLITUS; DRUG ISOLATION; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; DRUG TARGETING; ENZYME INHIBITION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LIVER PROTECTION; MOLECULAR DOCKING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; STRUCTURE ACTIVITY RELATION;

GLYCOGEN PHOSPHORYLASE; HYPOGLYCEMIC AGENTS; IRIDOID GLYCOSIDES; MOLECULAR DOCKING SIMULATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84884537945     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/J3FS4F     Document Type: Article

References (67)

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract, 2010; 87:4-14.
2. DeFronzo RA, Bonadonna RC, Ferannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care, 1992; 15:318-368.
3. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes, 1988; 37:1595-1607.
4. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes, 1992; 41:715-722.
5. Moller DE. New drug targets for type 2 diabetes and the metabolic syndrome. Nature, 2001; 414:821-827.
6. Grover JK, Yadav S, Vats V. Medicinal plants of India with anti-diabetic potential. J Ethnopharmacol, 2002; 81:81-100.
7. Bailey CJ, Day C. Metformin: Its botanical background. Pract Diab Inter, 2004; 21:115-117.
8. Dinda B, Debnath S, Y. H. Naturally Occurring Secoiridoids and Bioactivity of Naturally Occurring Iridoids and Secoiridoids. A Review, Part 2 Chem Pharm Bull, 2007; 55:689-728.
9. Wu SY, Wang GF, Liu ZQ, Rao JJ, Lu L, Xu W, et al. Effect of geniposide, a hypoglycemic glucoside, on hepatic regulating enzymes in diabetic mice induced by a high-fat diet and streptozotocin. Acta Pharmacol Sin, 2009; 30:202-208.
10. Bianco A. The Chemistry of Iridoids in Studies in Natural Products Chemistry. Amsterdam: Elsevier Science Publishers;1990.
11. Bianco A. Recent developments in iridoids chemistry. Pure Appl Chem, 1994; 66:2335-2338.
12. Roth LM, Eisner T. Chemical Defenses of Arthropods. Ann Rev Entomo, 1962; 7:107.
13. Tundis R, Loizzo MR, Menichini F, Statti GA, Menichini F. Biological and pharmacological activities of iridoids: recent developments. Mini Rev Med Chem, 2008; 8:399-420.
14. Ghisalberti EL. Biological and pharmacological activity of naturally occurring iridoids and secoiridoids. Phytomedicine, 1998; 5:147-163.
15. Halpern O, Schmid H. Zur Kenntnis des Plumierids. 2. Mitteilung. Helv Chim Acta, 1958; 41:1109-1154.
16. El-Naggar LJ, Beal JL. Iridoids. A review. J Nat Prod, 1980; 43:649-707.
17. Junior P. Recent Developments in the Isolation and Structure Elucidation of Naturally Occurring Iridoid Compounds. Planta Med, 1990; 56:1-13.
18. Damtoft S, Franzyk H, Jensen SR. Biosynthesis of secoiridoids in Fontanesia. Phytochemistry, 1995; 38:615-621.
19. Foderaro TA, Stermitz FR, H. H. (5aH)-6- Epidihydrocornin, the First Known Iridoid Glycoside With a Trans-fused Ring System. Tetrahedron Lett, 1992; 33:2953-2954.
20. Boros CA, Stermitz FR. Iridoids, an up-dated review, Part II. J Nat Prod, 1991; 54:1173-1246.
21. Cornforth JW. The chiral methyl group--its biochemical significance. Chem Britain, 1970; 6:431-435.
22. Otsuka H. Two iridoid glycoside caffeoyl esters from Premna odorata. Phytochemistry, 1993; 33:617-622.
23. Inouye H, Uesato S. Biosynthesis of iridoids and secoiridoids. Prog Chem Org Nat Prod, 1986; 50:169-236.
24. Jensen J, Serup P, Karlsen C, Nielsen TF, Madsen OD. mRNA profiling of rat islet tumors reveals nkx 6.1 as a beta-cell-specific homeodomain transcription factor. J Biol Chem, 1996; 271:18749-18758.
25. Anwar M, Ahmad M, Aslam M, Aftab K. Enicostema littorale: a new source of swertiamarin. Pak J Pharm Sci, 1996; 9:29-35.
26. Vishwakarma SL, Rajani M, Goyal RK. Comparative antidiabetic activity of different fractions of Enicostemma littorale Blume. in STZ induced NIDDM rats. OPEM, 2003; 3:196-204.
27. Vishwakarma SL, Rajani M, Bagul MS, Goyal RK. A rapid method for the isolation of swertiamarin from Enicostemma littorale. Pharm Biol, 2004; 42:400-403.
28. Vaidya H, Mandapati R, Vasudevan S, Padh H, Goyal RK. Antihyperlipidaemic activity of swertiamarin, a secoiridoid glycoside in poloxamer- 407-induced hyperlipidaemic rats. J Nat Med, 2009; 63:437-442.
29. Vaidya H, Mandapati R, Vasudevan S, Padh H, Goyal RK. Swertiamarin: A lead from Enicostemma littorale Blume. for anti-hyperlipidaemic effect. Eur J Pharmacol, 2009; 617:108-112.
30. Vaidya H, Prajapati A, Rajani M, Sudarsanam V, Padh H, Goyal RK. Beneficial Effects of Swertiamarin on Dyslipidaemia in Streptozotocininduced Type 2 Diabetic Rats. Phytother Res, 2012; 26:1259-1261.
31. Vaijanathappa J, Badami S. Antiedematogenic and free radical scavenging activity of swertiamarin isolated form Enicostemma axillare. Planta Med, 2009; 75:12-17.
32. Danbuo, Y. editor. Zabing Guagyao. 2 ed. China: People's Health Publishers, PR China; 1984.
33. Wang, X. editor. Zhongyi Neike Bianzheng Xue. 1 ed. China: P. R. China: People's Health Publishers; 1991.
34. Krauss S, Zhang CY, Lowell BB. A significant portion of mitochondrial proton leak in intact thymocytes depends on expression of UCP2. Proc Natl Acad Sci USA, 2002; 99:118-122.
35. Chen-Yu Z, Laura EP, Chian Ping Ye, Krauss S, Ruichao Shen, Cheng-Ting Lin, et al. Genipin inhibits UCP2-mediated proton leak and acutely reverses obesity- and high glucose-induced β cell dysfunction in isolated pancreatic islets. Cell Metab, 2006; 3:417-427.
36. Stupans I, Kirlich A, Tuck KL, Hayball PJ. Comparison of radical scavenging effect, inhibition of microsomal oxygen free radical generation, and serum lipoprotein oxidation of several natural antioxidants. J Agric Food Chem, 2002; 50:2464-2469.
37. Visioli F, Bellomo G, Galli C. Free radical scavenging properties of olive oil polyphenols. Biochem Biophys Res Commun, 1998; 247:60-64.
38. Visioli F, Bellomo G, Montedoro G, Galli C. Low density lipoprotein oxidation is inhibited in vitro by olive oil constituents. Atherosclerosis, 1995; 117:25-32.
39. De lCJ, Quintero L, Villalobos MA, Sanchez dl, Cuseta F. Lipid peroxidation and glutathione system in hyperlipemic rabbits: influence of olive oil administration. Biochim Biophys Acta, 2000; 1485:36-44.
40. Carluccio MA, Siculella L, Ancora MA, Massaro M, Scoditti E, Storelli C, et al. Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler Thromb Vasc Biol, 2003; 23:622-629.
41. Kris-Etherton PM, Hecke KD, Bonanome A, Coval SM, Binkoski AE, Hilpert KF, et al. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med, 2002; 113:71S-88.
42. Speroni E, Guerra MC, Minghetti A, Crespi- Perellino N, Pasini P, Piazza F. Oleuropein evaluated in vitro and in vivo as an antioxidant. Phytother Res, 1998; 12:S98-100.
43. Chimi H, Cillard J, Cillard P, Rahmani M. Peroxyl and hydroxyl radical scavenging activity of some natural phenolic antioxidants. J Am Oil Chem Soc, 1991; 68:307-312.
44. Hedya Jemai, Abdelfattah El Feki, Sayadi S. Antidiabetic and Antioxidant Effects of Hydroxytyrosol and Oleuropein from Olive Leaves in Alloxan-Diabetic Rats. J Agric Food Chem, 2009; 57:8798-8804.
45. Gonzalez M, Zarzuelo A, Gamez MJ, Utrilla MP, Jimenez J, Osuna I. Hypoglycemic activity of olive leaf. Planta Med, 1992; 58:513-515.
46. Calis I, Zor M, Basaran AA, Karsoside. Scropolioside D, Two New iridoid Glycosides from Scrophularia ilwensis. J Nat Prod, 1993; 56:606-609.
47. Bhandari SP, Mishra A, Roy R, Garg HS. Koelzioside, an iridoid diglycoside from Scrophularia koelzii. Phytochemistry, 1992; 31:689-691.
48. Perry, LM; Metzger, J, editors. Medicinal Plants of Southeast Asia: MIT Press, Cambridge, MA and London, UK 1980.
49. Shabana MM, Mirhom YW, Genenah AA, Aboutabl EA, Amer HA. Study into wild Egyptian plants of potential medicinal activity. Ninth communication: hypoglycaemic activity of some selected plants in normal fasting and alloxanised rats. Arch Exp Veterinarymed, 1990; 44:389-394.
50. Fan C, Xiang QY. Phylogenetic relationships within cornus (cornaceae) based on 26s rdna sequences-1. Am J Bot, 2001; 88:1131-1138.
51. Yamabe N, Kang KS, Goto E, Tanaka T, Yokozawa T. Identification of Antidiabetic Effect of Iridoid Glycosides and Low Molecular Weight Polyphenol Fractions of Corni Fructus, a Constituent of Hachimi-jio-gan, in Streptozotocin-Induced Diabetic Rats. Biol Pharm Bull, 2007; 30:520-526.
52. Cooper ME, Bonnet F, Oldfield M, Jandeleit-Dahm K. Mechanisms of diabetic vasculopathy: an overview. Am J Hypertens, 2001; 14:475-486.
53. Xu HQ, Hao HP. Biological Effects of Iridoid Total Glycoside from Cornus officinalis on Prevention of Glomerular Overexpression of Transforming Growth Factor Beta 1 and Matrixes in an Experimental Diabetes Model. Biol Pharm Bull, 2004; 27:1014-1018.
54. Pailer M, Haschke Hofmeister E. Inhaltsttoffe aus Plantago major. Planta Med, 1969; 17:139-145.
55. Bianco A, Iavarone C, Trogolo C. Structure of eucommiol, A new cyclopentenoid-tetraol from Eucommia ulmoides. Tetrahedron, 1974; 30:4117-4121.
56. Bernini R, Iavarone C, Trogolo C. 1-O-β- - Glucopyranosyleucommiol, an iridoid glucoside from Aucuba japonica. Phytochemistry, 1984; 23:1431-1433.
57. Suomi J, Sirén H, Wiedmer SK, Riekkola ML. Isolation of aucubin and catalpol from Melitaea cinxia larvae and quantification by micellar elec trokinetic capillary chromatography. Anal Chim Acta, 2001; 429:91-99.
58. Sampio-Santos MK, M. Biosynthesis Significance of iridoids in chemosystematics. J Braz Chem Soc, 2001; 12:144-153.
59. Lei JH-Y, Xue.; Li-Ji, Jin.; Shu-Ying, Li.; Yong- Ping, Xu. Antioxidant and pancreas-protective effect of aucubin on rats with streptozotocin-induced diabetes. Eur J Pharmacol, 2007; 583:162-167.
60. Hong YX, LiJi J, Lei J, Z. P, Dan Qing L, Yan Qiu X, et al. Neuroprotection of aucubin in primary diabetic encephalopathy. Science in China Series C: Life Sci, 2008; 51:496-502.
61. Newgard CB, Hwang PK, Fletterick RJ. The family of glycogen phosphorylases: structure and function. Crit Rev Biochem Mol Biol, 1989; 24:69-99.
62. Rath VL, Ammirati M, Danley DE, Ekstrom JL, Gibbs EM, Hynes TR, et al. Human liver glycogen phosphorylase inhibitors bind at a new allosteric site. Chem Biol, 2000; 7:677-682.
63. Hazai E, Kovacs S, Demko L, Bikadi Z. DockingServer (www.dockingserver.com) Virtua Drug Ltd., Budapest, Hungary [cited 2012 Jan 2012].
64. Halgren TA. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J Comp Chem, 1996; 17:490-519.
65. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comp Chem, 1998; 19:1639-1662.
66. Francisco J. Solis, Wets RJ-B. Minimization by Random Search Techniques. Math oper res, 1981; 6:19-30.
67. Zhang CY, Parton LE, Ye CP, Krauss S, Shen R, Lin CT, et al. Genipin inhibits UCP2-mediated proton leak and acutely reverses obesity- and high glucose-induced beta cell dysfunction in isolated pancreatic islets. Cell Metab, 2006; 3:417-427.